Terms: = Endocrine gland cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Treatment
168 results:
1. cdk4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcinoma.
Cheng K; Zhou Z; Chen Q; Chen Z; Cai Y; Cai H; Wu S; Gao P; Cai Y; Zhou J; Wang X; Wu Z; Peng B
Sci Rep; 2024 Apr; 14(1):8389. PubMed ID: 38600093
[TBL] [Abstract] [Full Text] [Related]
2. Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.
Shim SH; Lee JY; Lee YY; Park JY; Lee YJ; Kim SI; Han GH; Yang EJ; Noh JJ; Yim GW; Son JH; Kim NK; Kim TH; Kong TW; Choi YJ; Cho A; Lim H; Jang EB; Cho HW; Suh DH
J Gynecol Oncol; 2024 Mar; 35(2):e66. PubMed ID: 38330382
[TBL] [Abstract] [Full Text] [Related]
3. TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort.
Cruz-Romero SD; González S; Juez JY; Becerra DS; Baldión AM; Hakim JA; González-Devia D; Perdomo S; Rodríguez-Urrego PA
Adv Ther; 2024 Feb; 41(2):792-805. PubMed ID: 38170436
[TBL] [Abstract] [Full Text] [Related]
4. cdk4 phosphorylation status and rational use for combining cdk4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
Pita JM; Raspé E; Coulonval K; Decaussin-Petrucci M; Tarabichi M; Dom G; Libert F; Craciun L; Andry G; Wicquart L; Leteurtre E; Trésallet C; Marlow LA; Copland JA; Durante C; Maenhaut C; Cavaco BM; Dumont JE; Costante G; Roger PP
Front Endocrinol (Lausanne); 2023; 14():1247542. PubMed ID: 37964967
[TBL] [Abstract] [Full Text] [Related]
5. Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer.
Kang HW; Kim JH; Lee DE; Lee YS; Kim MJ; Kim HS; Fang S; Lee BE; Lee KJ; Yoo J; Kim HJ; Park JS
Cancer Biol Ther; 2023 Dec; 24(1):2272334. PubMed ID: 37917550
[TBL] [Abstract] [Full Text] [Related]
6. A real-world analysis of trametinib in combination with hydroxychloroquine or cdk4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma.
Tang H; Ge Y; You T; Li X; Wang Y; Cheng Y; Bai C
BMC Cancer; 2023 Oct; 23(1):958. PubMed ID: 37817078
[TBL] [Abstract] [Full Text] [Related]
7. p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer.
Bai F; Liu X; Zhang X; Mao Z; Wen H; Ma J; Pei XH
Cell Cycle; 2023 Jul; 22(13):1637-1653. PubMed ID: 37345432
[TBL] [Abstract] [Full Text] [Related]
8. Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
9. Inhibiting cdk4/6 in pancreatic ductal adenocarcinoma via microRNA-21.
Mortoglou M; Miralles F; Mould RR; Sengupta D; Uysal-Onganer P
Eur J Cell Biol; 2023 Jun; 102(2):151318. PubMed ID: 37105116
[TBL] [Abstract] [Full Text] [Related]
10. Differentiated Thyroid cancer in Adolescents: Single Center Experience and Considerations for Surgical Management and Radioiodine treatment.
Chiapponi C; Hartmann MJM; Decarolis B; Simon T; Bruns CJ; Faust M; Schultheis AM; Schmidt M; Alakus H
J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):257-263. PubMed ID: 36987773
[TBL] [Abstract] [Full Text] [Related]
11. A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas.
Hidalgo M; Garcia-Carbonero R; Lim KH; Messersmith WA; Garrido-Laguna I; Borazanci E; Lowy AM; Medina Rodriguez L; Laheru D; Salvador-Barbero B; Malumbres M; Shields DJ; Grossman JE; Huang X; Tammaro M; Martini JF; Yu Y; Kern K; Macarulla T
Cancer Res Commun; 2022 Nov; 2(11):1326-1333. PubMed ID: 36970055
[TBL] [Abstract] [Full Text] [Related]
12. The effects of Abemaciclib on cell cycle and apoptosis regulation in anaplastic thyroid cancer cells.
Abutorabi ES; Poursheikhani A; Kashani B; Shamsaiegahkani S; Haghpanah V; Bashash D; Mousavi SA; Momeny M; Ghaffari SH
Mol Biol Rep; 2023 May; 50(5):4073-4082. PubMed ID: 36877344
[TBL] [Abstract] [Full Text] [Related]
13. [Arguments for centralization of surgical treatment of ovarian cancer in France based on morbidity and mortality data].
Meurette J; Daraï E; Tajahmady A; Fouard A; Ducastel A; Collin-Bund V; Jochum F; Lecointre L; Querleu D; Akladios C
Bull Cancer; 2024 Mar; 111(3):239-247. PubMed ID: 36797128
[TBL] [Abstract] [Full Text] [Related]
14. MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by cdk4/6 and lysosomal inhibition.
Silvis MR; Silva D; Rohweder R; Schuman S; Gudipaty S; Truong A; Yap J; Affolter K; McMahon M; Kinsey C
J Exp Med; 2023 Mar; 220(3):. PubMed ID: 36719686
[TBL] [Abstract] [Full Text] [Related]
15. Combined inhibition of ACLY and cdk4/6 reduces cancer cell growth and invasion.
Velez BC; Petrella CP; DiSalvo KH; Cheng K; Kravtsov R; Krasniqi D; Krucher NA
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562384
[TBL] [Abstract] [Full Text] [Related]
16. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.
Tong Y; Sun M; Chen L; Wang Y; Li Y; Li L; Zhang X; Cai Y; Qie J; Pang Y; Xu Z; Zhao J; Zhang X; Liu Y; Tian S; Qin Z; Feng J; Zhang F; Zhu J; Xu Y; Lou W; Ji Y; Zhao J; He F; Hou Y; Ding C
J Hematol Oncol; 2022 Nov; 15(1):168. PubMed ID: 36434634
[TBL] [Abstract] [Full Text] [Related]
17. Disulfiram/Copper Suppresses cancer Stem Cell Activity in Differentiated Thyroid cancer Cells by Inhibiting BMI1 Expression.
Ni YL; Chien PJ; Hsieh HC; Shen HT; Lee HT; Chen SM; Chang WW
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362068
[TBL] [Abstract] [Full Text] [Related]
18. Combination Therapies with cdk4/6 Inhibitors to Treat KRAS-Mutant Pancreatic cancer.
Goodwin CM; Waters AM; Klomp JE; Javaid S; Bryant KL; Stalnecker CA; Drizyte-Miller K; Papke B; Yang R; Amparo AM; Ozkan-Dagliyan I; Baldelli E; Calvert V; Pierobon M; Sorrentino JA; Beelen AP; Bublitz N; Lüthen M; Wood KC; Petricoin EF; Sers C; McRee AJ; Cox AD; Der CJ
Cancer Res; 2023 Jan; 83(1):141-157. PubMed ID: 36346366
[TBL] [Abstract] [Full Text] [Related]
19. Synthesis and anti-tumor activity of nitrogen-containing derivatives of the natural product diphyllin.
Li Y; Lu Q; Xiao R; Ma J; Tang Y; Chen W; Zhang R; Jiang L; Chen H; Shen B; Zhang A; Ding C
Eur J Med Chem; 2022 Dec; 243():114708. PubMed ID: 36122549
[TBL] [Abstract] [Full Text] [Related]
20. Role of cdk4/6 inhibitors in patients with hormone receptor (HR)-positive, human epidermal receptor-2 negative (HER-2) metastatic breast cancer study protocol for a systematic review, network meta-analysis and cost-effectiveness analysis.
Hu Q; Kang W; Wang Q; Luo T
BMJ Open; 2022 May; 12(5):e056374. PubMed ID: 35636793
[TBL] [Abstract] [Full Text] [Related]
[Next]
